This led to the development of new tauopathy models based on the intracranial injection of extracellular pathological tau species to be close to the non-cell-autonomous mechanisms (Ahmed et al., 2014; Peeraer et al., 2015). The gene discussed is MAPT; the disease is tauopathy.